ΔR/R0	change in fluorescence ratio, normalized to control ratio
ACSF	artificial cerebrospinal fluid
DIV	days in vitro
DMSO	dimethyl sulfoxide
DTT	1,4-dithio-DL-threitol
DPI	diphenyleneiodonium chloride
E0′roGFP	standard redox potential
EroGFP	roGFP reduction potential
F 380max/F 380min	fluorescence ratio at 380 nm excitation, Ca2+-free/Ca2+-saturated
F 395/F 470	fluorescence ratio at 395 nm excitation and 470 nm excitation
F 470ox	fluorescence intensity at 470 nm excitation, fully oxidized
F 470ox/F 470red	fluorescence ratio at 470 nm, fully oxidized/fully reduced
F 470red	fluorescence intensity at 470 nm excitation, fully reduced
FCCP	carbonyl cyanide 4-(trifluoromethoxy)phenylhydrazone
FCS	fetal calf serum
HBSS	Hanks’-balanced salt solution
HEPES	4-(2-hydroxyethyl)piperazine-1-ethanesulfonic acid
MAP2	microtubule associated protein 2
MeCP2	methyl-CpG binding protein 2, protein
MECP2	methyl-CpG binding protein 2, encoding gene (human)
Mecp2	methyl-CpG binding protein 2, encoding gene (mouse)
Mecp2−/y	MeCP2-deficient male mouse (hemizygous)
Mecp2+/−	MeCP2-deficient female mouse (heterozygous)
MEM	minimal essential medium
NOX	NADPH oxidase
OxDroGFP	relative degree of roGFP oxidation
PBS	phosphate buffered saline
R	fluorescence ratio
roGFP	reduction oxidation-sensitive green fluorescent protein
roGFPc	roGFP expressed in cytosol
roGFPm	roGFP expressed in mitochondrial matrix
ROS	reactive oxygen species
Rox	ratio corresponding to full oxidation
Rred	ratio corresponding to full reduction
RTT	Rett syndrome
SOD1	superoxide dismutase 1, Cu/Zn superoxide dismutase
WT	wildtype
XO	xanthine oxidase
XDH	xanthine dehydrogenase